These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 4611464

  • 1. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB, Vesell ES.
    Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract] [Full Text] [Related]

  • 2. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
    Reidenberg MM, Vesell ES.
    Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
    [Abstract] [Full Text] [Related]

  • 3. Anomalous results of studies on drug interaction in man. II. Halofenate (mk-185) and antipyrine, bishydroxycoumarin, and warfarin.
    Vesell ES, Passananti GT.
    Pharmacology; 1975 Jun; 13(2):112-27. PubMed ID: 49900
    [Abstract] [Full Text] [Related]

  • 4. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL, Wake CJ, Harber MJ.
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM, Routledge PA, Tsanaclis LM, Richens A.
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide.
    Back DJ, Tjia J, Mönig H, Ohnhaus EE, Park BK.
    Eur J Clin Pharmacol; 1988 May; 34(2):157-63. PubMed ID: 3383988
    [Abstract] [Full Text] [Related]

  • 7. [The serum tolbutamide picture during oral treatment of diabetes].
    Leubner H, Saito S.
    Wien Klin Wochenschr; 1970 May 01; 82(18):321-4. PubMed ID: 4930124
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of sulfamerazine and antipyrine in neonatal and young lambs.
    De Backer P, Belpaire FM, Bogaert MG, Debackere M.
    Am J Vet Res; 1982 Oct 01; 43(10):1744-51. PubMed ID: 7149373
    [Abstract] [Full Text] [Related]

  • 9. Half life of intravenous tolbutamide in the serum of patients in medical wards.
    Sotaniemi EA, Huhti E.
    Ann Clin Res; 1974 Jun 01; 6(3):146-54. PubMed ID: 4844125
    [No Abstract] [Full Text] [Related]

  • 10. Kinetics of warfarin absorption in man.
    Breckenridge A, Orme M.
    Clin Pharmacol Ther; 1973 Jun 01; 14(6):955-61. PubMed ID: 4584153
    [No Abstract] [Full Text] [Related]

  • 11. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L, Kristensen M, Hansen M, Siersbaek-Nielsen K.
    Acta Med Scand; 1976 Jun 01; 199(6):513-5. PubMed ID: 59517
    [Abstract] [Full Text] [Related]

  • 12. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS, Satyanarayana S, Visweswaram D.
    Br J Clin Pharmacol; 1994 Feb 01; 37(2):205-7. PubMed ID: 8186066
    [Abstract] [Full Text] [Related]

  • 13. Effects of tricyclic antidepressants on drug metabolism.
    Pond SM, Graham GG, Birkett DJ, Wade DN.
    Clin Pharmacol Ther; 1975 Aug 01; 18(2):191-9. PubMed ID: 50160
    [Abstract] [Full Text] [Related]

  • 14. Half-life of tolbutamide in patients with chronic respiratory failure.
    Sotaniemi E, Arvela P, Huhti E, Koivisto O.
    Eur J Clin Pharmacol; 1971 Dec 01; 4(1):29-31. PubMed ID: 5151390
    [No Abstract] [Full Text] [Related]

  • 15. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.
    Sartor G, Melander A, Scherstén B, Wåhlin-Boll E.
    Eur J Clin Pharmacol; 1980 Apr 01; 17(4):285-93. PubMed ID: 6995130
    [No Abstract] [Full Text] [Related]

  • 16. Two compartment analysis of plasma elimination of phenazone in normals and in patients with cirrhosis of the liver.
    Greisen G, Andreasen PB.
    Acta Pharmacol Toxicol (Copenh); 1976 Jan 01; 38(1):49-58. PubMed ID: 946370
    [No Abstract] [Full Text] [Related]

  • 17. [The effect of aging on pharmacokinetics and pharmacodynamics of tolbutamide].
    Ikegami H.
    Nihon Ronen Igakkai Zasshi; 1985 May 01; 22(3):218-23. PubMed ID: 4046215
    [No Abstract] [Full Text] [Related]

  • 18. Simple reversed-phase high-performance liquid chromatographic determination of antipyrine in rabbit plasma for pharmacokinetic studies.
    De Beer JO, Jacobs GA, Martens MA.
    J Chromatogr; 1984 May 11; 307(2):475-80. PubMed ID: 6736197
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of warfarin following intravenous administration to man.
    O'Reilly RA, Welling PG, Wagner JG.
    Thromb Diath Haemorrh; 1971 May 11; 25(1):178-86. PubMed ID: 5577970
    [No Abstract] [Full Text] [Related]

  • 20. Influence of thyroid status on plasma half-life of antipyrine in man.
    Eichelbaum M, Bodem G, Gugler R, Schneider-Deters D, Dengler HJ.
    N Engl J Med; 1974 May 09; 290(19):1040-2. PubMed ID: 4821905
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.